Zoetis (CHIX:ZOED) Construction In Progress: €0 Mil (As of Mar. 2026)


CHIX:ZOED Zoetis Inc CHIX:ZOED
65 GF Score
Price €66.44
GF Value €178.04
Valuation Significantly Undervalued
View Full Analysis

What is Zoetis Construction In Progress?

Zoetis CHIX:ZOED 65 Construction In Progress is €0 Mil as of Mar. 2026. GuruFocus rates CHIX:ZOED with a GF Score™ of 65/100 and a GF Value™ of €178.04 (Significantly Undervalued).

Zoetis's quarterly construction in progress increased from Sep. 2025 (€0 Mil) to Dec. 2025 (€1,106 Mil) but then declined from Dec. 2025 (€1,106 Mil) to Mar. 2026 (€0 Mil).

Zoetis's annual construction in progress increased from Dec. 2023 (€995 Mil) to Dec. 2024 (€1,292 Mil) but then declined from Dec. 2024 (€1,292 Mil) to Dec. 2025 (€1,106 Mil).

Zoetis Construction In Progress Historical Data

* Premium members only.

The historical data trend for Zoetis's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zoetis Construction In Progress Chart

Zoetis Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 656.67 768.42 994.95 1,292.12 1,105.93

Zoetis Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 1,105.93 0.00
CHIX:ZOED
65GF Score
Zoetis Inc CHIX:ZOED
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zoetis Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of €0 Mil mean?
Zoetis (CHIX:ZOED) has a Construction In Progress of €0 Mil as of Mar. 2026. Construction in Progress records the amount of construction work that is not complete. View historical data on Zoetis and its competitors.
Is Zoetis' Construction In Progress too high?
Zoetis' current Construction In Progress is €0 Mil. Overall, Zoetis has a GF Score™ of 65/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zoetis' Construction In Progress compare to UTHR and VTRS?
Zoetis' Construction In Progress of €0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Drug Manufacturers company?
A good Construction In Progress depends on the Drug Manufacturers industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Zoetis and its competitors. Zoetis's current Construction In Progress is €0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zoetis stock overvalued right now?
Based on GuruFocus' analysis, Zoetis (CHIX:ZOED) is currently considered Significantly Undervalued. The stock's GF Value™ is €178.04, compared to a current price of €66.44 — trading 62.7% below its estimated fair value. The current Construction In Progress is €0 Mil. Zoetis' overall GF Score™ is 65/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Zoetis (CHIX:ZOED), the current Construction In Progress is €0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zoetis (CHIX:ZOED) Overvalued in 2026?

Based on GuruFocus' analysis, Zoetis stock appears to be undervalued. The current stock price of €66.44 is trading 62.7% below its estimated GF Value™ of €178.04. GuruFocus considers Zoetis to be Significantly Undervalued.

Key valuation signals for CHIX:ZOED:

  • Construction In Progress: €0 Mil
  • GF Value™: €178.04 vs. price of €66.44 (62.7% below fair value)
  • GF Score™: 65/100

No single metric tells the full story. See the CHIX:ZOED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zoetis Business Description

Address 10 Sylvan Way, Parsippany, NJ, USA, 07054
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
65GF Score

Get the complete analysis for CHIX:ZOED

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€66.44
Price
€178.04
GF Value